LLMpediaThe first transparent, open encyclopedia generated by LLMs

Monod–Wyman–Changeux model

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Jean-Pierre Changeux Hop 5
Expansion Funnel Raw 3 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted3
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Monod–Wyman–Changeux model
NameMonod–Wyman–Changeux model
AuthorsJacques Monod; Jeffries Wyman; Jean-Pierre Changeux
Year1965
FieldBiochemistry; Structural biology; Theoretical biology

Monod–Wyman–Changeux model The Monod–Wyman–Changeux model is a landmark allosteric model proposing concerted conformational transitions in oligomeric proteins, first articulated by Jacques Monod, Jeffries Wyman, and Jean-Pierre Changeux in 1965. It provides a theoretical framework linking ligand binding and conformational states in multimeric proteins and has influenced research in enzymology, structural biology, pharmacology, and molecular evolution. The model is central to understanding regulatory mechanisms in hemoglobin, acetylcholine receptor, and enzyme complexes studied across laboratories and institutions worldwide.

Introduction

The Monod–Wyman–Changeux model was introduced by researchers associated with institutions such as the Pasteur Institute, Harvard University, and the Collège de France, and it addresses cooperative behavior in proteins like hemoglobin, which was studied by contemporaries including Max Perutz, Linus Pauling, and John Kendrew. The model posits that oligomeric proteins exist in equilibrium between discrete conformational states, an idea that resonated with findings from groups at the Medical Research Council, the California Institute of Technology, and the Max Planck Society. It contrasts with sequential views advocated by researchers influenced by work at institutions such as the Rockefeller University and the University of Cambridge, shaping debates in the fields championed by Nobel laureates including Perutz and Pauling.

Historical development and context

The formulation emerged amid mid-20th century advances exemplified by achievements from the Pasteur Institute, Cambridge University, and the Massachusetts Institute of Technology, and it was informed by structural and biochemical discoveries from laboratories led by Perutz, Pauling, and Kendrew. Monod, Wyman, and Changeux presented the concerted model in the same era that saw landmark contributions from the Nobel committees recognizing work at institutions like the Royal Society, the National Institutes of Health, and the Institut Pasteur. Debates between proponents of concerted mechanisms and sequential mechanisms paralleled dialogues involving figures at the University of Chicago, Columbia University, and Princeton University, and were shaped by experimental programs in biophysics at the Max Planck Institute and Cold Spring Harbor Laboratory.

Mathematical formulation

The Monod–Wyman–Changeux model defines an equilibrium between at least two states, often designated as tense and relaxed, and formalizes ligand binding using parameters akin to affinity constants characterized by techniques developed at institutions such as the University of Oxford, ETH Zurich, and Stanford University. Its equations relate population ratios to ligand concentration using a limited set of parameters, analogous to mathematical treatments employed in theoretical work at the Institute for Advanced Study and research groups linked to the California Institute of Technology and Johns Hopkins University. The model's algebraic structure has been taught in courses at Harvard Medical School, Yale School of Medicine, and University College London, and used in computational implementations at Lawrence Berkeley National Laboratory and Los Alamos National Laboratory.

Applications in allostery and enzymology

The Monod–Wyman–Changeux model has been applied to classical systems including hemoglobin studied by Perutz at the Medical Research Council and to enzyme complexes analyzed in laboratories at the Pasteur Institute and the Salk Institute. It has informed drug discovery programs at pharmaceutical companies and collaborations with research centers like the National Institute of Allergy and Infectious Diseases, the Wellcome Trust Centre, and the European Molecular Biology Laboratory. The model is invoked in studies of ligand-gated ion channels researched at institutions such as the Scripps Research Institute, Columbia University, and Rockefeller University, and in metabolic enzyme regulation work associated with the University of California, San Francisco, and the Broad Institute.

Experimental evidence and validation

Experimental validation for the Monod–Wyman–Changeux model comes from X-ray crystallography by groups including those of Perutz and Kendrew, cryo-electron microscopy conducted at institutions like the Max Planck Institute and the European Molecular Biology Laboratory, and spectroscopic studies from laboratories at MIT, Stanford, and Caltech. Key supportive experiments involved hemoglobin variants characterized in research programs at the University of Chicago and the Medical Research Council, as well as mutagenesis and ligand-binding assays performed at Cold Spring Harbor Laboratory and the Pasteur Institute. Single-molecule and rapid kinetics experiments from teams at Harvard, Columbia, and Johns Hopkins have provided additional quantitative tests of model predictions.

Extensions and generalizations

Extensions of the Monod–Wyman–Changeux model have been developed by researchers at institutions such as Rockefeller University, Princeton University, and the University of Cambridge, incorporating heterogeneity, intermediate states, and allosteric modulators studied at the Salk Institute and the Wellcome Trust Center. Generalizations include models used in structural studies at the Max Planck Society and computational frameworks from research groups at MIT, the Broad Institute, and Lawrence Livermore National Laboratory, which integrate energy landscapes and statistical mechanics methods akin to work from the Institute for Advanced Study. Hybrid models combining concerted and sequential features have been formulated in collaborations involving NIH-funded centers and European consortia.

Criticisms and alternatives

Critiques of the Monod–Wyman–Changeux model were articulated by scientists influenced by work at the University of Cambridge, the University of Oxford, and the Rockefeller University, who favored sequential or induced-fit explanations stemming from research traditions linked to Pauling and Kendrew. Alternative frameworks, including the sequential model promoted by proponents at institutions such as Caltech and Columbia, and energy landscape approaches advanced at the Max Planck Institute and Princeton University, offer different mechanistic interpretations and have motivated experimental programs at Cold Spring Harbor Laboratory and the Wellcome Trust Centre. Ongoing debate continues in academic settings including Harvard, Yale, and ETH Zurich, where integrative approaches seek to reconcile diverse empirical findings.

Category:Biochemistry Category:Allosteric regulation Category:Enzymology